# ACT-293987 in Pulmonary Arterial Hypertension

> **NCT01112306** · PHASE3 · COMPLETED · sponsor: **Actelion** · enrollment: 709 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** ACT-293987

## Key facts

- **NCT ID:** NCT01112306
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07-07
- **Primary completion:** 2021-08-26
- **Final completion:** 2021-08-26
- **Target enrollment:** 709 (ACTUAL)
- **Last updated:** 2025-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01112306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01112306, "ACT-293987 in Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01112306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*